Target intelligence / Profile preview

RE1-silencing transcription factor mRNA 3′ untranslated region (REST mRNA 3′UTR)

Target
REST mRNA 3′UTR
Molecular classification
RNA, Untranslated region, Regulatory element
01

Overview

The RE1-silencing transcription factor (REST) mRNA 3′ untranslated region (3′UTR) is a critical regulatory segment that controls the post-transcriptional expression of the REST protein, a master repressor of neuronal genes (Chong et al., 1995). REST, also known as the neuron-restrictive silencer factor (NRSF), plays a vital role in maintaining neuronal identity and protecting neurons from various stressors (Lu et al., 2014). The 3′UTR contains multiple microRNA response elements (MREs) that serve as binding sites for miRNAs such as miR-124, miR-9, and miR-153-3p, which regulate REST levels by inducing mRNA degradation or inhibiting translation (Rivera et al., 2023). Dysregulation of this 3′UTR-mediated control is linked to several neurodegenerative diseases, including Alzheimer's disease and amyotrophic lateral sclerosis (ALS), where altered REST levels contribute to neuronal loss (Wang et al., 2024). Additionally, the REST mRNA 3′UTR is involved in oncogenesis, particularly in brain tumors like glioblastoma, where REST can act as an oncogene (Jin et al., 2023). Therapeutic interventions targeting this region, such as miRNA mimics or antisense oligonucleotides, aim to modulate REST expression to restore cellular homeostasis. These RNA-based strategies represent a promising frontier for treating complex neurological and malignant conditions by fine-tuning the expression of this essential transcription factor.

Other names
NRSF mRNA 3′UTRNeuron-restrictive silencer factor mRNA 3′UTRXBR mRNA 3′UTRRE1-silencing transcription factor 3′ untranslated region
02

Mechanism of action

Modulation of REST protein expression through miRNA-mediated translational repression or mRNA degradation by targeting specific response elements within the 3′UTR.

03

Biological functions

Post-transcriptional regulationmRNA stabilityTranslation inhibitionNeurogenesis regulationSynaptic plasticity
04

Disease associations

Alzheimer's diseaseAmyotrophic lateral sclerosisHuntington's diseaseGlioblastomaMedulloblastomaCardiac hypertrophy
05

Safety considerations

Off-target effects of miRNA mimicsBlood-brain barrier delivery challengesSystemic toxicity of RNA delivery vehiclesPotential for unintended global gene expression changes
06

Interacting drugs

miR-153-3p mimic

4 more in the full profile.

07

Biomarkers

REST mRNA levelsREST protein levelsmiR-153-3p expressionmiR-124 expression

Beyond the preview

Go deeper on RE1-silencing transcription factor mRNA 3′ untranslated region (REST mRNA 3′UTR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RE1-silencing transcription factor mRNA 3′ untranslated region (REST mRNA 3′UTR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call